Elite Pharmaceuticals, Inc.
Elite Pharmaceuticals, Inc. (ELTP) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · ELTP · as of Jun 9, 2026
Activity summary
Buy transactions
1
P-Purchase only
Sell transactions
5
12 Months
Buy/Sell ratio
0.20
Buy/Sell (by trades)
Overall sentiment
Elite Pharmaceuticals, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 9, 2026
ELTP insider buying and selling by quarter
ELTP insider selling · ELTP insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 9, 2026
Active insiders
Most active in past 12 months · ELTP ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
ELTP executive sell shares · ELTP board member insider trading · ELTP insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Aug 25, 2025 | ELITE PHARMACEUTICALS INC /NV/ EVP Operations | Option | 2,500,000 | $75K | Form 4 |
| Aug 22, 2025 | ELITE PHARMACEUTICALS INC /NV/ EVP Operations | Sale | 500,000 | $262K | Form 4 |
| Jul 10, 2025 | Kirkov Kirko Chief Commercial Officer | Purchase | 16,366 | $10K | Form 4 |
| Oct 23, 2024 | Plassche Douglas SVP of Operations | Sale | 800,000 | $392K | Form 4 |
| Oct 24, 2024 | Plassche Douglas SVP of Operations | Sale | 333,932 | $170K | Form 4 |
| Mar 29, 2024 | Hakim Nasrat A CEO, President · Director | Award | 49,534,368 | — | Form 4 |
| Dec 29, 2023 | Hakim Nasrat A CEO, President · Director | Award | 2,223,147 | $153K | Form 4 |
| Nov 22, 2023 | WHITNELL JEFFREY A Director | Award | 547,657 | $20K | Form 4 |
| Nov 22, 2023 | Caskey Davis S Director | Award | 547,657 | $20K | Form 4 |
| Nov 22, 2023 | Dash Barry H Director | Award | 547,657 | $20K | Form 4 |
| Aug 28, 2022 | WHITNELL JEFFREY A Director | Award | 459,536 | $20K | Form 4 |
| Aug 28, 2022 | Caskey Davis S Director | Award | 459,536 | $20K | Form 4 |
| Aug 28, 2022 | Dash Barry H Director | Award | 459,536 | $20K | Form 4 |
| Jun 30, 2021 | WHITNELL JEFFREY A Director | Award | 295,570 | $20K | Form 4 |
| Jun 30, 2021 | Caskey Davis S Director | Award | 295,570 | $20K | Form 4 |
| Jun 30, 2021 | Dash Barry H Director | Award | 295,570 | $20K | Form 4 |
| Aug 24, 2020 | Hakim Nasrat A CEO & President · Director | Other | 158,017,321 | — | Form 4 |
| Aug 20, 2020 | Plassche Douglas SVP Operations | Award | 71,739 | $6K | Form 4 |
| Aug 20, 2020 | Caskey Davis S Director | Award | 516,781 | $45K | Form 4 |
| Aug 20, 2020 | WHITNELL JEFFREY A Director | Award | 516,781 | $45K | Form 4 |
| Aug 20, 2020 | Dash Barry H Director | Award | 516,781 | $45K | Form 4 |
| Jun 30, 2020 | Plassche Douglas SVP of Operations | Award | 574,597 | $50K | Form 4 |
| Feb 26, 2018 | Pfeifer Eugene M Director | Award | 161,374 | $20K | Form 4 |
| Feb 26, 2018 | Plassche Douglas SVP of Operations | Award | 201,717 | $25K | Form 4 |
| Feb 26, 2018 | Ward Carter Julian CFO, Sec., Treas. | Award | 242,060 | $30K | Form 4 |
ELITE PHARMACEUTICALS INC /NV/
EVP Operations
Date
Aug 25
Shares
2,500,000
Price
$0.03
Value
$75K
ELITE PHARMACEUTICALS INC /NV/
EVP Operations
Date
Aug 22
Shares
500,000
Price
$0.52
Value
$262K
Kirkov Kirko
Chief Commercial Officer
Date
Jul 10
Shares
16,366
Price
$0.59
Value
$10K
Plassche Douglas
SVP of Operations
Date
Oct 23
Shares
800,000
Price
$0.49
Value
$392K
Plassche Douglas
SVP of Operations
Date
Oct 24
Shares
333,932
Price
$0.51
Value
$170K
Hakim Nasrat A
CEO, President · Director
Date
Mar 29
Shares
49,534,368
Price
—
Value
—
Hakim Nasrat A
CEO, President · Director
Date
Dec 29
Shares
2,223,147
Price
$0.07
Value
$153K
Hakim Nasrat A
CEO & President · Director
Date
Aug 24
Shares
158,017,321
Price
—
Value
—
Plassche Douglas
SVP of Operations
Date
Jun 30
Shares
574,597
Price
$0.09
Value
$50K
Plassche Douglas
SVP of Operations
Date
Feb 26
Shares
201,717
Price
$0.12
Value
$25K
Ward Carter Julian
CFO, Sec., Treas.
Date
Feb 26
Shares
242,060
Price
$0.12
Value
$30K
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About ELTP insider trading
ELTP insider trades
Elite Pharmaceuticals, Inc. (ELTP) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including ELITE PHARMACEUTICALS INC /NV/ (EVP Operations), Kirkov Kirko (Chief Commercial Officer). Over the past 12 months, 2 insiders have filed transactions with the SEC. ELTP insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Elite Pharmaceuticals, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
ELTP insider trading · 5 questionsThe insiders of Elite Pharmaceuticals, Inc. (ELTP) include executives and directors such as ELITE PHARMACEUTICALS INC /NV/ (EVP Operations), Kirkov Kirko (Chief Commercial Officer), among others. Over the past 12 months, 2 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026